Lista de obras -

A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo

artículo científico publicado en 2021

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

artículo científico publicado en 2022

ARCHITECT HIV Combo Ag/Ab® and RealTime® HIV-1 assays detect diverse HIV strains in clinical specimens

artículo científico publicado en 2017

An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots

artículo científico publicado en 2017

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

artículo científico publicado en 2015

Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States

artículo científico publicado en 2017

Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimens

artículo científico publicado en 2015

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

artículo científico publicado en 2016

Author Correction: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

scientific article published on 01 March 2020

Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L

scientific article published on 01 March 2020

Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes

artículo científico publicado en 2014

Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.

artículo científico publicado en 2016

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

artículo científico publicado en 2016

Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity

artículo científico publicado en 2015

Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays

artículo científico publicado en 2013

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

artículo científico publicado en 2015

Development and performance of prototype serologic and molecular tests for hepatitis delta infection

artículo científico publicado en 2018

Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2.

artículo científico publicado en 2016

Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples

scientific article published on 26 June 2018

Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.

artículo científico publicado en 2017

Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.

artículo científico publicado en 2017

Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing

artículo científico publicado en 2014

HBV RNA profiles in chronic hepatitis B patients under different disease phases and anti-viral therapy

artículo científico publicado en 2020

HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals

artículo científico publicado en 2014

HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapy

artículo científico publicado en 2014

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients

artículo científico publicado en 2017

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

artículo científico publicado en 2018

HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term Nonprogression.

artículo científico publicado en 2016

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage

artículo científico publicado en 2017

Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection

artículo científico publicado en 2018

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

artículo científico publicado en 2016

Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders

artículo científico publicado en 2017

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

artículo científico publicado en 2017

Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort

artículo científico publicado en 2018

High frequency of genotype D and spontaneous hepatitis B virus genomic mutations among Haitians in a multiethnic North American population.

artículo científico publicado en 2013

High prevalence of hepatitis delta virus in Cameroon

scientific article published in Scientific Reports

Identification of Hepatitis B virus genotype I in Thailand

article

Identification of a putative novel genotype 3/rabbit hepatitis E virus (HEV) recombinant

scientific article published in PLoS ONE

Impact of the New Abbott mPLUS feature on clinical laboratory efficiencies of abbott RealTime assays for detection of HIV-1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae

scientific article published on 02 October 2013

Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy

artículo científico publicado en 2014

Increased HIV in Greater Kinshasa Urban Health Zones: Democratic Republic of Congo (2017-2018)

artículo científico publicado en 2020

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

scientific article published on 13 January 2020

Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir ⬇️

artículo científico publicado el 25 de julio de 2013

NEW GENOMES FROM THE CONGO BASIN EXPAND HISTORY OF CRF01_AE ORIGIN AND DISSEMINATION

scientific article published on 12 April 2020

Performance of the Abbott RealTime HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations ⬇️

artículo científico publicado el 2 de febrero de 2011

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

artículo científico publicado en 2014

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

artículo científico publicado en 2016

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation

artículo científico publicado en 2020

Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo

artículo científico publicado en 2017

Sequence Conservation of the Region Targeted by the Abbott RealTime HBV Viral Load Assay in Clinical Specimens ⬇️

artículo científico publicado el 23 de enero de 2013

Sequence conservation of the region targeted by the Abbott RealTime HCV viral load assay

artículo científico publicado en 2014

The new hepatitis C paradigm: a synergy of diagnostics and drug therapy

artículo científico publicado en 2014

Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR

artículo científico publicado en 2007

Universal Target Capture of HIV Sequences From NGS Libraries

article

Lista de obras de

A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

ARCHITECT HIV Combo Ag/Ab® and RealTime® HIV-1 assays detect diverse HIV strains in clinical specimens

An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States

Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimens

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

Author Correction: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L

Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes

Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity

Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

Development and performance of prototype serologic and molecular tests for hepatitis delta infection

Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2.

Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples

Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.

Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.

Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing

HBV RNA profiles in chronic hepatitis B patients under different disease phases and anti-viral therapy

HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals

HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapy

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term Nonprogression.

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage

Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort

High frequency of genotype D and spontaneous hepatitis B virus genomic mutations among Haitians in a multiethnic North American population.

High prevalence of hepatitis delta virus in Cameroon

Identification of Hepatitis B virus genotype I in Thailand

Identification of a putative novel genotype 3/rabbit hepatitis E virus (HEV) recombinant

Impact of the New Abbott mPLUS feature on clinical laboratory efficiencies of abbott RealTime assays for detection of HIV-1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae

Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy

Increased HIV in Greater Kinshasa Urban Health Zones: Democratic Republic of Congo (2017-2018)

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir ⬇️

NEW GENOMES FROM THE CONGO BASIN EXPAND HISTORY OF CRF01_AE ORIGIN AND DISSEMINATION

Performance of the Abbott RealTime HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations ⬇️

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation

Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo

Sequence Conservation of the Region Targeted by the Abbott RealTime HBV Viral Load Assay in Clinical Specimens ⬇️

Sequence conservation of the region targeted by the Abbott RealTime HCV viral load assay

The new hepatitis C paradigm: a synergy of diagnostics and drug therapy

Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR

Universal Target Capture of HIV Sequences From NGS Libraries